GC녹십자 CEO Huh Eun-chul announces plans to secure US sales for Alyglo through plasma centers, expecting improved profitability as all six centers receive FDA approval.
#YonhapInfomax #GC녹십자 #Alyglo #PlasmaCenter #FDAApproval #ABOHoldings #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63133
#YonhapInfomax #GC녹십자 #Alyglo #PlasmaCenter #FDAApproval #ABOHoldings #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63133